Evidence map›Paper›PMID 10498871›Full record

ArticleOncogene1999

Requirement of protein kinase (Krs/MST) activation for MT-21-induced apoptosis.

M Watabe, H Kakeya, H Osada

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Oncogene, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. MST1 promotes apoptosis through phosphorylation of histone H2AX.The Journal of biological chemistry · 2010
    Article
  6. Article
  7. The human WW45 protein enhances MST1-mediated apoptosis in vivo.International journal of molecular medicine · 2009
    Article
  8. A decade of caspases.Oncogene · 2003
    Review
  9. Article
  10. Article
  11. Caspase cleavage of MST1 promotes nuclear translocation and chromatin condensation.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M WatabeLaboratory of Antibiotics, The Institute of Physical and Chemical Research (RIKEN), 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
H Kakeya
H Osada
RIKEN · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fas is a well characterized apoptosis-inducing factor. One of our synthetic compounds, MT-21, induced apoptosis in human leukemia HL-60 cells similar to Fas. MT-21 activated caspase-3, an important cysteine aspartic protease for apoptosis induction. MT-21 also activated c-Jun-NH2-terminal kinase (JNK), a member of mitogen activated protein kinase (MAPK) superfamily that is involved in the regulation of cell growth, differentiation and cell death. Moreover, MT-21 treatment resulted in the activation of a 36 kDa kinase which uses myelin basic protein (MBP) as a substrate. However, MAPK and p38 were not activated by treatment with MT-21. The 36 kDa MBP kinase was shown to be a proteolytic product derived from the Krs protein with a molecular weight of 60 kDa. The Krs protein is a Ser/Thr protein kinase whose activity is enhanced by digestion of its C-terminal regulatory domain by caspase-3. When a kinase-inactive mutant form of Krs protein was overexpressed in HL-60 cells, JNK activation and apoptosis induction by MT-21 were suppressed. Furthermore, overexpression of dominant negative c-Jun also suppressed apoptosis induction by MT-21. These findings indicate that MT-21 induces apoptosis by the activation of JNK via the Krs protein, which is activated by caspase cleavage.

Indexed as

Mitogen-Activated Protein KinasesAmino Acid SubstitutionApoptosisCalcium-Calmodulin-Dependent Protein KinasesCaspase 3CaspasesDNA FragmentationDNA, NeoplasmEnzyme ActivationFas Ligand Proteinfas ReceptorGenes, junHippo KinasesHL-60 CellsHumansIntracellular Signaling Peptides and ProteinsCalcium-Calmodulin-Dependent Protein KinasesCASP3 protein, humanCaspase 3CaspasesDNA, NeoplasmFASLG protein, humanFas Ligand Proteinfas ReceptorHippo KinasesIntracellular Signaling Peptides and ProteinsJNK Mitogen-Activated Protein KinasesMembrane GlycoproteinsMitogen-Activated Protein KinasesMT 21Myelin Basic ProteinNeoplasm ProteinsPeptide FragmentsPoly(ADP-ribose) PolymerasesProtein Serine-Threonine KinasesPyrrolesReactive Oxygen SpeciesSerine-Threonine Kinase 3STK3 protein, humanSTK4 protein, human

Identifiers

PMID10498871
OpenAlexW2081342821

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.